Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Repeat pituitary ablation for advanced prostatic cancer.

O Khan, J Allen, G Williams

Postgraduate Medical Journal

|May 1, 1985

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Partial pituitary ablation with implants of gold-198 and yttrium-90 for Cushing's syndrome with associated adrenal hyperplasia.

British medical journal·2010

Same author

Partial pituitary ablation with implants of gold-198 and yttrium-90 for acromegaly.

British medical journal·2010

Same author

Virilism with Hilus Cell Hyperplasia.

Proceedings of the Royal Society of Medicine·2009

Same author

Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3 beta-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/Pakistani origin.

Human molecular genetics·1994

Same author

Why patients choose to purchase a hearing aid privately.

British journal of audiology·1992

Same author

Peripheral insulin administration attenuates the increase in neuropeptide Y concentrations in the hypothalamic arcuate nucleus of fasted rats.

Peptides·1992

Interstitial pituitary irradiation using yttrium-90 can relieve pain in advanced prostate cancer. Complete pituitary ablation is necessary for sustained pain relief, and anterior pituitary function should be monitored.

Area of Science:

Endocrinology
Oncology
Radiotherapy

Background:

Advanced prostatic adenocarcinoma often requires significant pain management.
Interstitial pituitary irradiation with yttrium-90 is a treatment option for pain palliation.

Observation:

A patient with advanced prostate cancer experienced temporary pain relief after initial yttrium-90 pituitary implantation.
Partial ablation of anterior pituitary function was noted post-initial treatment.

Findings:

A second yttrium-90 implantation achieved complete pituitary ablation.
Full and sustained pain relief was only achieved after complete pituitary ablation.

Implications:

Monitoring anterior pituitary function is recommended for patients undergoing pituitary ablation for prostate cancer.

Related Experiment Videos

This is particularly important for patients with progressive disease despite initial treatment response.